NCT00005055View on ClinicalTrials.gov

Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

March 31, 2001

Conditions
Lung Cancer
Interventions
DRUG

glufosfamide

Trial Locations (1)

44805

CRLCC Nantes - Atlantique, Nantes-Saint Herblain

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00005055 - Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter